RT Journal Article
SR Electronic
T1 Racial and ethnic disparities in COVID-19 disease incidence independent of comorbidities, among people with HIV in the US
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.12.07.21267296
DO 10.1101/2021.12.07.21267296
A1 RA Bender Ignacio
A1 AE Shapiro
A1 RM Nance
A1 BM Whitney
A1 JAC Delaney
A1 L Bamford
A1 D Wooten
A1 M Karris
A1 WC Mathews
A1 HN Kim
A1 SE Van Rompaey
A1 JC Keruly
A1 G Burkholder
A1 S Napravnik
A1 KH Mayer
A1 J Jacobson
A1 MS Saag
A1 RD Moore
A1 JJ Eron
A1 AL Willig
A1 KA Christopoulos
A1 J Martin
A1 PW Hunt
A1 HM Crane
A1 MM Kitahata
A1 E Cachay
A1 for the Centers for AIDS Research Network of Integrated Clinical Systems (CNICS)
YR 2021
UL http://medrxiv.org/content/early/2021/12/08/2021.12.07.21267296.abstract
AB Objectives To define the incidence of clinically-detected COVID-19 in people with HIV (PWH) in the US and evaluate how racial and ethnic disparities, comorbidities, and HIV-related factors contribute to risk of COVID-19.Design Observational study within the CFAR Network of Integrated Clinical Systems cohort in 7 cities during 2020.Methods We calculated cumulative incidence rates of COVID-19 diagnosis among PWH in routine care by key characteristics including race/ethnicity, current and lowest CD4 count, and geographic area. We evaluated risk factors for COVID-19 among PWH using relative risk regression models adjusted with disease risk scores.Results Among 16,056 PWH in care, of whom 44.5% were Black, 12.5% were Hispanic, with a median age of 52 years (IQR 40-59), 18% had a current CD4 count < 350, including 7% < 200; 95.5% were on antiretroviral therapy, and 85.6% were virologically suppressed. Overall in 2020, 649 PWH were diagnosed with COVID-19 for a rate of 4.94 cases per 100 person-years. The cumulative incidence of COVID-19 was 2.4-fold and 1.7-fold higher in Hispanic and Black PWH respectively, than non-Hispanic White PWH. In adjusted analyses, factors associated with COVID-19 included female sex, Hispanic or Black identity, lowest historical CD4 count <350 (proxy for CD4 nadir), current low CD4/CD8 ratio, diabetes, and obesity.Conclusions Our results suggest that the presence of structural racial inequities above and beyond medical comorbidities increased the risk of COVID-19 among PWHPWH with immune exhaustion as evidenced by lowest historical CD4 or current low CD4:CD8 ratio had greater risk of COVID-19.Competing Interest StatementThe authors have declared no competing interest.Funding StatementWe gratefully acknowledge the CNICS cohort participants and their providers for contributing to the study. Funding for this study and for CNICS came from the National Institute of Allergy and Infectious Diseases (NIAID) [CNICS R24 AI067039; UW CFAR NIAID Grant P30 AI027757; UAB CFAR grant P30 AI027767; UNC CFAR grant P30 AI50410; UCSD CFAR grant P30 AI036214 and by the Office of the President of the University of California COVID-19 seed grant; Case Western Reserve University CFAR grant P30 AI036219; Fenway Health/Harvard CFAR grant P30 AI060354, UCSF CFAR grant P30AI027763 and JHU CFAR grant P30 AI094189] and the National Institute on Drug Abuse (NIDA) [R01DA047045].Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:CFAR Network of Integrated Clinical Systems (CNICS) research has been approved by the institutional review boards at each site (Johns Hopkins University, Case Western Reserve University, Fenway Health, University of Alabama at Birmingham, University of California-San Diego, University of North Carolina at Chapel Hill, and University of Washington). Sites were anonymized per regulatory requirements of some sites.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors